1. 000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102). (1st September 2005) Authors: du Bois, A.; Schroeder, W.; Jelic, S.; Weber, B.; Sehouli, J.; Keern, J.; Priou, F.; Huober, J.; Railing, M.; Ray-Coquard, I.; Heilmann, V.; Surges, A.; Pfisterer, J.; Gropp, M.; Staehle, A.; Wimberger, P.; Jackisch, C.; Mueller, H. H. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102). (1st October 2006) Authors: Pujade-Lauraine, E.; Lueck, H. J.; Bertelsen, K.; Mueller, H. H.; Hogberg, T.; Platini, C.; Canzler, U.; Schroeder, W.; Sehouli, J.; Du Bois, A. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 00096 PRE-OPERATIVE SELECTION CRITERIA FOR OPERABILITY IN RECURRENT OVARIAN CANCER (DESKTOP-OVAR). (1st September 2005) Authors: du Bois, A.; Hahmann, M.; Schroeder, W.; Muenstedt, C.; Schmalfeldt, B.; Emons, G.; Pfisterer, J.; Wollschlaeger, K.; Meerpohl, H. G.; Breitbach, G. P.; Tanner, B.; Sehouli, J.; Heilmann, V; Lueck, H. J.; Kuhn, W.; Wimberger, P.; Ortmann, O.; Harter, P. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 0072: Safety and Pharmacokinetic Aspects of Anti-Angiogenic Therapy with Ptk787/Zk 222584 in Combination with Paclitaxel/Carboplatin in Patients with Ovarian Cancer. (1st October 2006) Authors: Schroeder, W.; Campone, M.; Abadie, S.; Witteveen, P. O.; Viens, P.; Jalava, T.; Palacay-Radona, M.; Bilic, S.; Laurent, D.; Du Bois, A. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. (1st January 2006) Authors: Rudlowski, C.; Pickart, A.-K.; Fuhljahn, C.; Friepoertner, T.; Schlehe, B.; Biesterfeld, S.; Schroeder, W. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 1 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗